84611-43-8

Basic information

• Product Name: PYRIDINE, 2-CHLORO-5-(PHENYLMETHOXY)-
• Synonyms: 2-CHLORO-5-(PHENYLMETHOXY)-PYRIDINE;PYRIDINE, 2-CHLORO-5-(PHENYLMETHOXY)-;5-(benzyloxy)-2-chloropyridine;2-Chloro-5-benzyloxypyridine
• CAS NO: 84611-43-8
• Molecular Formula: C₁₂H₁₀ClNO
• Molecular Weight: 219.67
• Mol File: 84611-43-8.mol
• Article Data: 19

Chemical Properties

• Appearance: /
• Density: 1.225
• Storage Temp.: 2-8°C
• CAS DataBase Reference: PYRIDINE, 2-CHLORO-5-(PHENYLMETHOXY)-(CAS DataBase Reference)
• NIST Chemistry Reference: PYRIDINE, 2-CHLORO-5-(PHENYLMETHOXY)-(84611-43-8)
• EPA Substance Registry System: PYRIDINE, 2-CHLORO-5-(PHENYLMETHOXY)-(84611-43-8)

Safety Data

• Hazardous Substances Data: 84611-43-8(Hazardous Substances Data)

Usage

General Description

Pyridine, 2-chloro-5-(phenylmethoxy)- is a chemical compound that consists of a pyridine ring with a chlorine atom at the 2-position and a phenylmethoxy group at the 5-position. It is commonly used as an intermediate in the synthesis of pharmaceuticals, agrochemicals, and other organic compounds. Pyridine, 2-chloro-5-(phenylmethoxy)- is known for its potential as a building block in the development of new drugs, as well as its use in research and development in the chemical industry. Moreover, it has various applications in the field of organic chemistry, making it a valuable and versatile compound in chemical synthesis.

Upstream product

• 41288-96-4 6-chloropyridine-3-ol 
• 100-39-0 benzyl bromide 
• 53939-30-3 5-bromo-2-chloropyridine 
• 100-51-6 benzyl alcohol 
• 69045-79-0 2-choro-5-iodopyridine 
• 100-44-7 benzyl chloride 

Downstream Products

• 630120-99-9 5-(benzyloxy)-2-bromopyridine 
• 287114-37-8 6-(piperazin-1-yl)pyridin-3-ol 
• 823197-36-0 1-(5-benzyloxy-2-pyridyl)-4-methanesulfonylpiperazine 
• 1204483-50-0 5-benzyloxy-2-(2-phenyl-[1,3]dioxan-5-yloxy)pyridine 
• 109-00-2 3-HYDROXYPYRIDINE 
• 823197-35-9 1-[5-(benzyloxy)pyridin-2-yl]piperazine 

Relevant articles and documents

MALIC ENZYME INHIBITORS

The present invention relates to novel compounds useful as malic enzyme (ME) inhibitors, processes for their preparation and use of these compounds for the therapeutic treatment of disorders mediated by ME such as cancers (e.g. pancreatic ductal adenocarcinoma (PDAC)) in humans.

COMPOUNDS AND THEIR METHODS OF USE

The present invention is directed to, in part, fused heteroaryl compounds and compositions useful for preventing and/or treating a disease or condition relating to aberrant function of a voltage-gated, sodium ion channel, for example, abnormal late/persistent sodium current. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including Dravet syndrome or epilepsy are also provided herein.

COMPOUNDS AND COMPOSITIONS AS MODULATORS OF GPR119 ACTIVITY

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of GPR119.